This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Konrad Bleicher, PhD
Expert Scientist at F. Hoffmann-La Roche Ltd.

Profile

Konrad Bleicher holds a Ph.D. in Organic Chemistry which he received from the Tübingen University in Germany. He started his professional career at Sandoz/Novartis (Switzerland & US) where he gained experience in the area of Combinatorial Chemistry before joining Roche as a scientist in the CNS chemistry department. Since then he has been holding various positions in the Small Molecule Medicinal Chemistry area (Hit ID, Lead ID and Lead Optimization). In 2009 Dr. Bleicher was nominated “Peptide Area Head”, overseeing the peptide chemistry activities in Pharma Research & Early Development. Since 2016 he is responsible for the RNA Therapeutics Chemistry strategy and platform development in Roche Basel. He is the author of over 80 patents and publications and an invited speaker for various international conferences.

Agenda Sessions

  • Advanced Backbone Chemistry for ASO Therapeutics

    On Demand
  • Medicinal Chemistry of RNA Therapeutics

    15:45
  • SESSION NAME: Medicinal Chemistry of RNA Therapeutics SESSION CHAIR:

    On Demand